Citation: | Chen ZY,Hu SQ,Liu DW,et al.Research advances on severe burn infection and cytokine storm[J].Chin J Burns Wounds,2023,39(4):391-395.DOI: 10.3760/cma.j.cn501225-20220412-00134. |
[1] |
TianH,WangLX,XieWG, et al. Epidemiologic and clinical characteristics of severe burn patients: results of a retrospective multicenter study in China, 2011-2015 [J/OL]. Burns Trauma, 2018,6:14[2022-04-12]. https://pubmed.ncbi.nlm.nih.gov/29850643/.DOI: 10.1186/s41038-018-0118-z.
|
[2] |
YoonJ,KymD,HurJ,et al.Comparative usefulness of sepsis-3, burn sepsis, and conventional sepsis criteria in patients with major burns[J].Crit Care Med,2018,46(7):e656-e662.DOI: 10.1097/CCM.0000000000003144.
|
[3] |
吴田田,童亚林,姚咏明.烧伤创面脓毒症的防治对策[J].创伤外科杂志,2017,19(5):396-400.DOI: 10.3969/j.issn.1009-4237.2017.05.020.
|
[4] |
SapanHB,PaturusiI,JusufI,et al.Pattern of cytokine (IL-6 and IL-10) level as inflammation and anti-inflammation mediator of multiple organ dysfunction syndrome (MODS) in polytrauma[J].Int J Burns Trauma,2016,6(2):37-43.
|
[5] |
FerraraJL.Cytokine dysregulation as a mechanism of graft versus host disease[J].Curr Opin Immunol,1993,5(5):794-799.DOI: 10.1016/0952-7915(93)90139-j.
|
[6] |
姚咏明,张卉,李春盛.脓毒症治疗新策略:免疫调理研究新认识[J].医学与哲学,2017,38(2B):28-31,42.DOI: 10.12014/j.issn.1002-0772.2017.02b.04.
|
[7] |
中国医疗保健国际交流促进会急诊医学分会,中华医学会急诊医学分会,中国医师协会急诊医师分会,等.中国脓毒症早期预防与阻断急诊专家共识[J].中国急救医学,2020,40(7):577-588.DOI: 10.3969/j.issn.1002-1949.2020.07.001.
|
[8] |
王玉亮,王峰,耿洁.细胞因子与细胞因子风暴[J].天津医药,2020,48(6):494-499.DOI: 10.11958/20200323.
|
[9] |
TisoncikJR,KorthMJ,SimmonsCP,et al.Into the eye of the cytokine storm[J].Microbiol Mol Biol Rev,2012,76(1):16-32.DOI: 10.1128/MMBR.05015-11.
|
[10] |
ZhouHT,LuXY,HuangJ,et al.Induction of trained immunity protects neonatal mice against microbial sepsis by boosting both the inflammatory response and antimicrobial activity[J].J Inflamm Res,2022,15:3829-3845.DOI: 10.2147/JIR.S363995.
|
[11] |
MulderPPG,VligM,BoekemaBKHL,et al.Persistent systemic inflammation in patients with severe burn injury is accompanied by influx of immature neutrophils and shifts in T cell subsets and cytokine profiles[J].Front Immunol,2021,11:621222.DOI: 10.3389/fimmu.2020.621222.
|
[12] |
唐远洋,罗高兴,贺伟峰.严重烧伤感染后细胞因子风暴发生发展机制浅析[J].四川大学学报(医学版),2021,52(1):16-21.DOI: 10.12182/20210160206.
|
[13] |
PandolfiF,AltamuraS,FrosaliS,et al.Key role of DAMP in inflammation, cancer, and tissue repair[J].Clin Ther,2016,38(5):1017-1028.DOI: 10.1016/j.clinthera.2016.02.028.
|
[14] |
TeacheyDT,LaceySF,ShawPA,et al.Identification of predictive biomarkers for cytokine release syndrome after chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia[J].Cancer Discov,2016,6(6):664-679.DOI: 10.1158/2159-8290.CD-16-0040.
|
[15] |
DucharmeJ,SelfWH,OsbornTM,et al.A multi-mRNA host-response molecular blood test for the diagnosis and prognosis of acute infections and sepsis: proceedings from a clinical advisory panel[J].J Pers Med,2020,10(4):266.DOI: 10.3390/jpm10040266.
|
[16] |
AhmedAI,SolimanRA,SamirS.Cell free DNA and procalcitonin as early markers of complications in ICU patients with multiple trauma and major surgery[J].Clin Lab,2016,62(12):2395-2404.DOI: 10.7754/Clin.Lab.2016.160615.
|
[17] |
JonssonN,NilsenT,Gille-JohnsonP,et al.Calprotectin as an early biomarker of bacterial infections in critically ill patients: an exploratory cohort assessment[J].Crit Care Resusc,2017,19(3):205-213.
|
[18] |
胡时强,毛远桂,刘德伍,等.严重烧伤脓毒症诊治的研究进展[J].江西医药,2019,54(3):286-288,291.DOI: 10.3969/j.issn.1006-2238.2019.3.034.
|
[19] |
LeeDW,GardnerR,PorterDL,et al.Current concepts in the diagnosis and management of cytokine release syndrome[J].Blood,2014,124(2):188-195.DOI: 10.1182/blood-2014-05-552729.
|
[20] |
BaranP,HansenS,WaetzigGH,et al.The balance of interleukin (IL)-6, IL-6·soluble IL-6 receptor (sIL-6R), and IL-6·sIL-6R·sgp130 complexes allows simultaneous classic and trans-signaling[J].J Biol Chem,2018,293(18):6762-6775.DOI: 10.1074/jbc.RA117.001163.
|
[21] |
DholariaBR,BachmeierCA,LockeF.Mechanisms and management of chimeric antigen receptor T-cell therapy-related toxicities[J].BioDrugs,2019,33(1):45-60.DOI: 10.1007/s40259-018-0324-z.
|
[22] |
ShankBR,DoB,SevinA,et al.Chimeric antigen receptor T cells in hematologic malignancies[J].Pharmacotherapy,2017,37(3):334-345.DOI: 10.1002/phar.1900.
|
[23] |
TanakaY,Martin MolaE.IL-6 targeting compared to TNF targeting in rheumatoid arthritis: studies of olokizumab, sarilumab and sirukumab[J].Ann Rheum Dis,2014,73(9):1595-1597.DOI: 10.1136/annrheumdis-2013-205002.
|
[24] |
ShakooryB,CarcilloJA,ChathamWW,et al.Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase Ⅲ trial[J].Crit Care Med,2016,44(2):275-281.DOI: 10.1097/CCM.0000000000001402.
|
[25] |
LeventogiannisK,KyriazopoulouE,AntonakosN,et al.Toward personalized immunotherapy in sepsis: the PROVIDE randomized clinical trial[J].Cell Rep Med,2022,3(11):100817.DOI: 10.1016/j.xcrm.2022.100817.
|
[26] |
ChuWM.Tumor necrosis factor[J].Cancer Lett,2013,328(2):222-225.DOI: 10.1016/j.canlet.2012.10.014.
|
[27] |
Cabrera-RiveraGL,Madera-SandovalRL,León-PedrozaJI,et al.Increased TNF-α production in response to IL-6 in patients with systemic inflammation without infection[J].Clin Exp Immunol,2022,209(2):225-235.DOI: 10.1093/cei/uxac055.
|
[28] |
MakosA,KuiperJH,KehoeO,et al.Psoriatic arthritis: review of potential biomarkers predicting response to TNF inhibitors[J].Inflammopharmacology,2023,31(1):77-87.DOI: 10.1007/s10787-022-01092-x.
|
[29] |
ConfalonieriM,SaltonF,FabianoF.Acute respiratory distress syndrome[J].Eur Respir Rev,2017,26(144):160116.DOI: 10.1183/16000617.0116-2016.
|
[30] |
BatzofinBM,SprungCL,WeissYG.The use of steroids in the treatment of severe sepsis and septic shock[J].Best Pract Res Clin Endocrinol Metab,2011,25(5):735-743.DOI: 10.1016/j.beem.2011.05.006.
|
[31] |
HemingN,SivanandamoorthyS,MengP,et al.Immune effects of corticosteroids in sepsis[J].Front Immunol,2018,9:1736.DOI: 10.3389/fimmu.2018.01736.
|
[32] |
HeF,SongY,YingWJ,et al.Effects of Ulinastatin on myocardial oxidative stress and inflammation in severely burned rats[J].Eur Rev Med Pharmacol Sci,2018,22(17):5719-5728.DOI: 10.26355/eurrev_201809_15840.
|
[33] |
ChiYF,LiuXY,ChaiJK.A narrative review of changes in microvascular permeability after burn[J].Ann Transl Med,2021,9(8):719.DOI: 10.21037/atm-21-1267.
|
[34] |
LongbrakeEE,HaflerDA.Siponimod chips away at progressive MS[J].Cell,2019,179(7):1440.DOI: 10.1016/j.cell.2019.11.034.
|
[35] |
GauthierJ,HirayamaAV,PurusheJ,et al.Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failure[J].Blood,2020,135(19):1650-1660.DOI: 10.1182/blood.2019002936.
|
[36] |
StaedtkeV,BaiRY,KimK,et al.Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome[J].Nature,2018,564(7735):273-277.DOI: 10.1038/s41586-018-0774-y.
|
[37] |
GrazioliA,AthaleJ,TanakaK,et al.Perioperative applications of therapeutic plasma exchange in cardiac surgery: a narrative review[J].J Cardiothorac Vasc Anesth,2020,34(12):3429-3443.DOI: 10.1053/j.jvca.2020.01.054.
|
[38] |
肖刘牛,钟燕霞,李树生.体外血液净化技术对脓毒症临床预后及细胞因子影响的Meta分析[J].临床荟萃,2022,37(1):5-13.DOI: 10.3969/j.issn.1004-583X.2022.01.001.
|